Literature DB >> 19176408

Premature mortality from general medical illnesses among persons with bipolar disorder: a review.

Babak Roshanaei-Moghaddam1, Wayne Katon.   

Abstract

OBJECTIVE: Despite recent evidence that patients with bipolar disorder are at increased risk of premature mortality resulting from general medical disorders, there has been no systematic review of published studies. The authors reviewed the literature to determine whether there is evidence of increased risk of mortality from general medical causes among patients with bipolar spectrum disorders.
METHODS: MEDLINE was searched from 1959 to 2007 with a focus on bipolar disorder and medical mortality. Published studies in English with more than 100 patients were included.
RESULTS: Seventeen studies were identified involving 331,000 patients with bipolar disorder, affective psychosis, affective disorder severe enough to require inpatient psychiatric care or treatment with lithium, or schizoaffective disorder (that is, bipolar spectrum disorders) meeting the inclusion criteria. Compared with age- and sex-matched control samples without mental illness in the general population, mortality ratios for death from natural causes and from specific general medical conditions, such as cardiovascular, respiratory, cerebrovascular, and endocrine disorders, were significantly higher among patients with bipolar spectrum disorders in most studies. This finding was more consistent in larger studies with more than 2,500 patients with bipolar spectrum disorders. Cumulatively, cardiovascular disorder appeared to be the most consistent cause of excess mortality in larger studies.
CONCLUSIONS: The available evidence suggests that bipolar spectrum disorders are associated with increased premature mortality secondary to general medical illnesses. Unhealthy lifestyle, biological factors, adverse pharmacologic effects, and disparities in health care are possible underlying causes for this excess mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19176408     DOI: 10.1176/ps.2009.60.2.147

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  85 in total

1.  Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature.

Authors:  Chris B Aiken; Carolyn Orr
Journal:  Psychiatry (Edgmont)       Date:  2010-05

2.  Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.

Authors:  Juliette M Slomka; John D Piette; Edward P Post; Sarah L Krein; Zongshan Lai; David E Goodrich; Amy M Kilbourne
Journal:  J Affect Disord       Date:  2012-02-21       Impact factor: 4.839

3.  Prevalence of metabolic syndrome in a predominantly cuban, psychiatrically ill, and homeless population.

Authors:  Rafael A Rivas-Vazquez; Iruma Bello; Manual Sarria; Noel D Fernandez; Gustavo J Rey
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization.

Authors:  Arad Kodesh; Inbal Goldshtein; Marc Gelkopf; Iris Goren; Gabriel Chodick; Varda Shalev
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-07       Impact factor: 4.328

5.  High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Authors:  Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein
Journal:  J Clin Psychiatry       Date:  2019-07-30       Impact factor: 4.384

6.  Bipolar disorder in primary care: a qualitative study of clinician and patient experiences with diagnosis and treatment.

Authors:  Joseph M Cerimele; John C Fortney; Jeffrey M Pyne; Geoffrey M Curran
Journal:  Fam Pract       Date:  2019-01-25       Impact factor: 2.267

7.  An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial.

Authors:  Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

Review 8.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

9.  Gender differences in health-related quality of life in patients with bipolar disorder.

Authors:  Maria Syl D de la Cruz; Zongshan Lai; David E Goodrich; Amy M Kilbourne
Journal:  Arch Womens Ment Health       Date:  2013-04-16       Impact factor: 3.633

Review 10.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.